Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francine E M Voncken

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Lancet (London, England)|June 24, 2021
Contemporary radiotherapy: present and futureRavi A Chandra, Florence K Keane, Francine E M Voncken, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 22, 2019
Diffusion-weighted MRI with ADC mapping for response prediction and assessment of oesophageal cancer: A systematic reviewSophie E Vollenbrock, Francine E M Voncken, Lambertus W Bartels, et al.
Clinical Nuclear Medicine|August 21, 2014
Detecting interval metastases and response assessment using 18F-FDG PET/CT after neoadjuvant chemoradiotherapy for esophageal cancerJurriën Stiekema, Daan Vermeulen, Erik Vegt, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 21, 2017
Radiation-induced liver injury mimicking liver metastases on FDG-PET-CT after chemoradiotherapy for esophageal cancer : A retrospective study and literature reviewFrancine E M Voncken, Berthe M P Aleman, Jolanda M van Dieren, et al.
European Journal of Cancer (Oxford, England : 1990)|March 7, 2017
The prognostic and potentially predictive value of the Laurén classification in oesophageal adenocarcinomaRosa T van der Kaaij, Petur Snaebjornsson, Francine E M Voncken, et al.
American Journal of Clinical Oncology|February 7, 2019
Elevated Pretreatment CEA and CA19-9 Levels are Related to Early Treatment Failure in Esophageal AdenocarcinomaRosa T van der Kaaij, Francine E M Voncken, Jolanda M van Dieren, et al.
Practical Radiation Oncology|December 2, 2019
Quantification of Esophageal Tumor Motion and Investigation of Different Image-Guided Correction StrategiesFrancine E M Voncken, Sareh Nakhaee, Barbara Stam, et al.
American Journal of Clinical Oncology|August 2, 2017
Advanced Age is Not a Contraindication for Treatment With Curative Intent in Esophageal CancerFrancine E M Voncken, Rosa T van der Kaaij, Karolina Sikorska, et al.
Practical Radiation Oncology|July 8, 2019
A Novel Liquid Fiducial Marker in Esophageal Cancer Image Guided Radiation Therapy: Technical Feasibility and Visibility on ImagingMélanie Machiels, Francine E M Voncken, Peng Jin, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 7, 2021
Motion-compensated FDG PET/CT for oesophageal cancerFrancine E M Voncken, Erik Vegt, Johanna W van Sandick, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Lancet (London, England)|June 24, 2021
Contemporary radiotherapy: present and futureRavi A Chandra, Florence K Keane, Francine E M Voncken, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 22, 2019
Diffusion-weighted MRI with ADC mapping for response prediction and assessment of oesophageal cancer: A systematic reviewSophie E Vollenbrock, Francine E M Voncken, Lambertus W Bartels, et al.
Clinical Nuclear Medicine|August 21, 2014
Detecting interval metastases and response assessment using 18F-FDG PET/CT after neoadjuvant chemoradiotherapy for esophageal cancerJurriën Stiekema, Daan Vermeulen, Erik Vegt, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 21, 2017
Radiation-induced liver injury mimicking liver metastases on FDG-PET-CT after chemoradiotherapy for esophageal cancer : A retrospective study and literature reviewFrancine E M Voncken, Berthe M P Aleman, Jolanda M van Dieren, et al.
European Journal of Cancer (Oxford, England : 1990)|March 7, 2017
The prognostic and potentially predictive value of the Laurén classification in oesophageal adenocarcinomaRosa T van der Kaaij, Petur Snaebjornsson, Francine E M Voncken, et al.
American Journal of Clinical Oncology|February 7, 2019
Elevated Pretreatment CEA and CA19-9 Levels are Related to Early Treatment Failure in Esophageal AdenocarcinomaRosa T van der Kaaij, Francine E M Voncken, Jolanda M van Dieren, et al.
Practical Radiation Oncology|December 2, 2019
Quantification of Esophageal Tumor Motion and Investigation of Different Image-Guided Correction StrategiesFrancine E M Voncken, Sareh Nakhaee, Barbara Stam, et al.
American Journal of Clinical Oncology|August 2, 2017
Advanced Age is Not a Contraindication for Treatment With Curative Intent in Esophageal CancerFrancine E M Voncken, Rosa T van der Kaaij, Karolina Sikorska, et al.
Practical Radiation Oncology|July 8, 2019
A Novel Liquid Fiducial Marker in Esophageal Cancer Image Guided Radiation Therapy: Technical Feasibility and Visibility on ImagingMélanie Machiels, Francine E M Voncken, Peng Jin, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 7, 2021
Motion-compensated FDG PET/CT for oesophageal cancerFrancine E M Voncken, Erik Vegt, Johanna W van Sandick, et al.
Pageof 3